Literature DB >> 9119483

Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia.

L K Husmann1, D L Yung, S K Hollingshead, J R Scott.   

Abstract

To investigate the role of putative virulence factors of Streptococcus pyogenes (group A streptococcus; GAS) in causing disease, we introduced specific mutations in GAS strain B514, a natural mouse pathogen, and tested the mutant strains in two models of infection. To study late stages of disease, we used our previously described mouse model (C3HeB/FeJ mice) in which pneumonia and systemic spread of the streptococcus follow intratracheal inoculation. To study the early stages of disease, we report here a model of long-term (at least 21 days) throat colonization following intranasal inoculation of C57BL/10SnJ mice. When the three emm family genes of GAS strain B514-Sm were deleted, the mutant showed no significant difference from the wild type in induction of long-term throat colonization or pneumonia. We inactivated the scpA gene, which encodes a complement C5a peptidase, by insertion of a nonreplicative plasmid and found no significant difference from the wild type in the incidence of throat colonization. However, there was a small but statistically significant decrease in the incidence of pneumonia caused by the scpA mutant. Finally, we demonstrated a very important effect of the hyaluronic acid capsule in both models. Following intranasal inoculation of mice with a mutant in which a nonreplicative plasmid was inserted into the hasA gene, which encodes hyaluronate synthase, we found that all bacteria recovered from the throats of the mice were encapsulated revertants. Following intratracheal inoculation with the hasA mutant, the incidence of pneumonia within 72 h was significantly reduced from that of the control strain (P = 0.006). These results indicate that the hyaluronic acid capsule of S. pyogenes B514 confers an important selective advantage for survival of the bacteria in the upper respiratory tract and is also an important determinant in induction of pneumonia in our model system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119483      PMCID: PMC175149          DOI: 10.1128/iai.65.4.1422-1430.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Alternate complement pathway activation by group A streptococci: role of M-protein.

Authors:  A L Bisno
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

2.  The lack of bactericidal effect of mouse blood for nonvirulent group A streptococci.

Authors:  G G WILEY
Journal:  J Immunol       Date:  1959-01       Impact factor: 5.422

3.  Mechanism of action of the group A streptococcal C5a inactivator.

Authors:  D E Wexler; D E Chenoweth; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

4.  Introduction of the emm6 gene into an emm-deleted strain of Streptococcus pyogenes restores its ability to resist phagocytosis.

Authors:  J Perez-Casal; M G Caparon; J R Scott
Journal:  Res Microbiol       Date:  1992 Jul-Aug       Impact factor: 3.992

5.  Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model.

Authors:  R Raeder; M D Boyle
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.

Authors:  Y Ji; L McLandsborough; A Kondagunta; P P Cleary
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

7.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

8.  Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.

Authors:  E Whitnack; E H Beachey
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

9.  Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci.

Authors:  B A Dougherty; I van de Rijn
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene.

Authors:  J R Scott; P C Guenthner; L M Malone; V A Fischetti
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  42 in total

1.  Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells.

Authors:  Jeries Jadoun; Osnat Eyal; Shlomo Sela
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 2.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm.

Authors:  Heather A O'Connell; Greg S Kottkamp; James L Eppelbaum; Bryan A Stubblefield; Sarah E Gilbert; Eric S Gilbert
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

4.  Role of VltAB, an ABC transporter complex, in viologen tolerance in Streptococcus mutans.

Authors:  Saswati Biswas; Indranil Biswas
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

5.  Streptococcus pneumoniae can utilize multiple sources of hyaluronic acid for growth.

Authors:  Carolyn Marion; Jason M Stewart; Mia F Tazi; Amanda M Burnaugh; Caroline M Linke; Shireen A Woodiga; Samantha J King
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

6.  Strain-Dependent Effect of Capsule on Transmission and Persistence in an Infant Mouse Model of Group A Streptococcus Infection.

Authors:  Luis Alberto Vega; Misu A Sanson; Brittany J Shah; Anthony R Flores
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

7.  Identification of rocA, a positive regulator of covR expression in the group A streptococcus.

Authors:  Indranil Biswas; June R Scott
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

8.  LiaS regulates virulence factor expression in Streptococcus mutans.

Authors:  Patrick Chong; Laura Drake; Indranil Biswas
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection.

Authors:  Shigefumi Okamoto; Shigetada Kawabata; Yutaka Terao; Hideaki Fujitaka; Yoshinobu Okuno; Shigeyuki Hamada
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 10.  Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.

Authors:  Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.